HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,124 | +7.8% | 34,872 | +2.5% | 0.02% | +10.5% |
Q2 2023 | $2,898 | +1.4% | 34,035 | -1.5% | 0.02% | 0.0% |
Q1 2023 | $2,859 | +15.8% | 34,549 | +10.1% | 0.02% | +5.6% |
Q4 2022 | $2,469 | -99.9% | 31,386 | +30.6% | 0.02% | +38.5% |
Q3 2022 | $1,779,000 | +233.1% | 24,035 | +193.5% | 0.01% | +225.0% |
Q2 2022 | $534,000 | -19.0% | 8,189 | -21.5% | 0.00% | +33.3% |
Q1 2022 | $659,000 | +24.8% | 10,431 | +4.8% | 0.00% | +50.0% |
Q4 2021 | $528,000 | -8.7% | 9,957 | +21.6% | 0.00% | -33.3% |
Q3 2021 | $578,000 | +30.2% | 8,186 | +22.8% | 0.00% | +50.0% |
Q2 2021 | $444,000 | -29.5% | 6,666 | +17.5% | 0.00% | -50.0% |
Q1 2021 | $630,000 | +14.8% | 5,672 | +22.6% | 0.00% | +33.3% |
Q4 2020 | $549,000 | +117.0% | 4,626 | +59.7% | 0.00% | +50.0% |
Q3 2020 | $253,000 | -64.1% | 2,896 | -52.9% | 0.00% | -60.0% |
Q3 2018 | $705,000 | -27.5% | 6,149 | -43.3% | 0.01% | -16.7% |
Q2 2018 | $972,000 | +13.8% | 10,839 | -7.1% | 0.01% | 0.0% |
Q1 2018 | $854,000 | -19.2% | 11,670 | -35.8% | 0.01% | -14.3% |
Q4 2017 | $1,057,000 | +415.6% | 18,191 | +156.9% | 0.01% | +600.0% |
Q2 2016 | $205,000 | -5.5% | 7,081 | +13.9% | 0.00% | 0.0% |
Q1 2016 | $217,000 | +42.8% | 6,216 | +32.3% | 0.00% | 0.0% |
Q4 2015 | $152,000 | -25.9% | 4,700 | -25.8% | 0.00% | -50.0% |
Q3 2015 | $205,000 | +147.0% | 6,336 | +217.1% | 0.00% | +100.0% |
Q2 2015 | $83,000 | -95.6% | 1,998 | -95.2% | 0.00% | -93.3% |
Q1 2015 | $1,867,000 | +3119.0% | 41,556 | +2569.0% | 0.02% | – |
Q4 2014 | $58,000 | -12.1% | 1,557 | -17.0% | 0.00% | -100.0% |
Q3 2014 | $66,000 | -2.9% | 1,876 | -2.1% | 0.00% | 0.0% |
Q2 2014 | $68,000 | +9.7% | 1,917 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $62,000 | -23.5% | 1,917 | -0.1% | 0.00% | 0.0% |
Q4 2013 | $81,000 | -69.0% | 1,918 | -70.7% | 0.00% | -50.0% |
Q3 2013 | $261,000 | +80.0% | 6,554 | +86.4% | 0.00% | +100.0% |
Q2 2013 | $145,000 | – | 3,517 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |